Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
This publisher only
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > List All Publishers > PharmaVision

PharmaVision

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare and investment community; performs due diligence research and provides expert commentary in healthcare. Reports combine expert opinion, scientific analysis, with market modeling to forecast delivery technologies, drugs and their potential revenue stream, key drivers and market trends.

 

PharmaVision

 


Use column headings to sort
Title Published
Price
Novel Antibodies & Therapeutic Proteins: Technology Challenges & Future Prospects
By: PharmaVision
... & leading technologies driving the field; evaluate the unmet clinical needs, product pipelines & technological challenges for the next generation of mAbs & TPs; identify the key regulatory, IP & reimbursement issues which face biopharmaceutical ...  |  more...
Search inside this report
8/1/2010       $1,566.00
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
By: PharmaVision
... the key therapeutic areas: cancer, CNS disorders, viral infectious diseases, ocular diseases, cardiovascular, metabolic and other conditions; identify key pharma & delivery specialists advancing RNAi-based therapeutics & diagnostics; gain an in-depth understanding of the technological ...  |  more...
Search inside this report
7/1/2009       $1,566.00
Delivering New Biopharmaceutical Therapies: Challenges & Opportunities
By: PharmaVision
... Sidney Taurel, Chairman and Chief Executive Officer Eli Lilly and Company A biopharmaceutical is defined as a medical drug (proteins including antibodies, nucleic acids, DNA, RNA or antisense oligonucleotides) which is produced using biotechnology. In ...  |  more...
Search inside this report
1/19/2009       $1,415.00
Stem Cell-Based Therapeutic Delivery: Challenges & Opportunities
By: PharmaVision
... all of the key therapeutic areas: autoimmune diseases, cardiovascular, CNS & hematological malignancies; identify key pharma & delivery specialists advancing the next generation of regenerative medicines; gain an in-depth understanding of the technological manufacturing & ...  |  more...
Search inside this report
12/15/2008       $1,415.00
Drug Delivery Technology: Revolutionizing CNS Therapies
By: PharmaVision
... infection, pain (both acute and chronic); chronic organic conditions such as neoplasms, seizure disorders; chronic degenerative disorders such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and other dementias, as well as the range of functional ...  |  more...
Search inside this report
12/13/2007       $1,270.00
Drug Delivery Technology: Developing a New Generation of Vaccines
By: PharmaVision
... vaccines for a wider range of diseases than was previously possible. The market looks set to explode over the next 5-10 years as a raft of new products based on these new technologies are developed ...  |  more...
Search inside this report
11/22/2007       $1,270.00
Drug Delivery Technology: Revolutionizing Diabetes Treatment
By: PharmaVision
... only route of administration was via subcutaneous injection. Whilst there have been marginal improvements in injectable devices - insulin “pens” - the recent approval of inhalable insulin is the first step to opening new opportunities ...  |  more...
Search inside this report
9/20/2007       $1,270.00
Drug Delivery Technologies Revolutionizing Cancer Therapies
By: PharmaVision
... and opportunities to increase the therapeutic index and ultimately deliver targeted therapies to cancer cells whilst minimizing off-target side effects.” Dr Cheryl Barton. The burden of disease cancer puts on society is huge. In 2000 ...  |  more...
Search inside this report
4/27/2007       $1,270.00
Drug Delivery Technologies Revolutionizing Cardiovascular Therapies
By: PharmaVision
... target specific areas of the vasculature. These advances will help to develop a new generation of medicines and devices to tackle the world’s leading killer.” Dr Cheryl Barton Cardiovascular disease (CVD) is the leading cause ...  |  more...
Search inside this report
4/7/2007       $1,270.00
Title Published
Price

Title Index:  # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: Monday - Thursday: 5:30am - 7:00pm EST
Fridays: 5:30am - 6:00pm EST

Email: customerservice@marketresearch.com
Copyright © 1999-2012, All Rights Reserved, MarketResearch.com
2/12/2012 - 32